Clinical Trial

EB-OC for the Treatment of Focal Chondral/Osteochondral Defects in the Knee

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
EB-OC is a tissue engineered osteochondral tissue graft comprising of a living tissue engineered cartilage layer attaching to a bone scaffold. The goal of this clinical trial is to learn about in the safety and efficacy of the EB-OC graft in participants who require repair of chondral/osteochondral defects of the knee. The main question it aims to answer is if the EB-OC graft works to regenerate osteochondral tissue comprising of native hyaline cartilage anchors to the regenerated bone. Participants will receive treatment of either the EB-OC Graft implantation in an arthrotomy procedure or abrasion chondroplasty. Researchers will compare results from the EB-OC graft to abrasion chondroplasty to assess overall safety and effectiveness.
Trial Details
NCT Number NCT06895889
Lead Sponsor Epibone, Inc.
Collaborators: MCRA
Conditions Chondral Defect, Osteochondral Defect
Enrollment 36 participants
Start Date 2026-01-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-26